NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Humanase Co., Ltd.

Humanase Co., Ltd.

Private
South KoreaHealthcare & Life Scienceshttps://www.humanase.co.kr/

Last Round

Grant

May 12, 2025

Total Funding Raised

$2.84M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Humanase Co., Ltd. is a drug discovery company that develops biomimetic organ-on-a-chip technology to create in-vitro platforms for new drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

organ-on-a-chipOoCanimal testing alternativebiomimetic chippreclinical testingdrug discoverymicrofluidics3D cell culturetoxicity testingin-vitro modelCRO servicesdisease modelingmulti-organ chipbody-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Humanase Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Humanase Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Humanase Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 12, 2025
GrantApr 1, 2024
GrantMay 1, 2023
AngelMay 1, 2023
GrantOct 1, 2022
Seed
Sep 1, 2022

Humanase Co., Ltd. Investors

Notable investors and investment history

Humanase Co., Ltd. investors
InvestorRounds
Ministry of Science and ICT of South KoreaGrant
Gachon UniversityGrant
BSK InvestmentSeed, Grant
FirstgateSeed
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors grew 124% MoM, reaching 3K.

  • May 12, 2025

    $2.38M grant from the Ministry of Science and ICT of South Korea.

Humanase Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Humanase Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Humanase Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range3
Year Founded2021
Last FundingMay 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.